Description
In recent years, cancer research and treatment advancements have significantly improved outcomes for patients facing various forms of cancer. Among these is Diffuse Large B-cell Lymphoma (DLBCL), a prevalent and aggressive type of non-Hodgkin lymphoma. DLBCL presents unique challenges in both its diagnosis and treatment, prompting an ongoing quest for deeper understanding and more effective therapeutic approaches. In this article, we delve into the causes, diagnosis, and treatment modalities associated with DLBCL, exploring the intricate interplay between medical science, patient care, and the pursuit of better outcomes. Let’s begin with some basics.